Scarica l'app Stockscreener
8.35
1.30%
-0.11
Dopo l'orario di chiusura:
8.42
0.07
+0.84%
Precedente Chiudi:
$8.46
Aprire:
$8.52
Volume 24 ore:
265.04K
Relative Volume:
1.59
Capitalizzazione di mercato:
$422.91M
Reddito:
-
Utile/perdita netta:
$-29.42M
Rapporto P/E:
-9.6121
EPS:
-0.8687
Flusso di cassa netto:
$-25.01M
1 W Prestazione:
+0.85%
1M Prestazione:
+12.23%
6M Prestazione:
+54.06%
1 anno Prestazione:
+167.20%
Intervallo 1D:
$8.22
$8.645
Intervallo di 1 settimana:
$7.82
$9.165
Portata 52W:
$2.6801
$9.32
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Nome
Eupraxia Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare EPRX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
8.35 | 428.48M | 0 | -29.42M | -25.01M | -0.8687 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2025-06-16 | Iniziato | Canaccord Genuity | Speculative Buy |
| 2025-02-21 | Iniziato | Craig Hallum | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
Is HBOS plc Preferred Security forming a double bottomWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn
(EPRX.WT.A) Advanced Trading Insights - Stock Traders Daily
Eupraxia Pharmaceuticals (TSX:EPRX) Trades With S&P/TSX Index - Kalkine Media
Here's Why We're Not At All Concerned With Eupraxia Pharmaceuticals' (TSE:EPRX) Cash Burn Situation - Yahoo Finance
(EPRX) Optimized Trading Opportunities (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Trading Strategy and Analysis - Stock Traders Daily
(EPRX) Market Performance Analysis (EPRX:CA) - Stock Traders Daily
Fed Watch: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEAR - baoquankhu1.vn
(EPRX.WT.A) Investment Analysis (EPRX.WT.A:CA) - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
Osteoarthritis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Merck, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma - Barchart.com
Osteoarthritis Pipeline 2025: MOA And ROA Insights, Clinical Trials Status, And Key Companies Involved By Delveinsight Merck, Peptinov, LG Chem, Akan Bioscience, Biotissue,Inc., Eupraxia Pharma - Menafn.com
Momentum Shift: Does Ainos Inc have strong fundamentalsPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
(EPRX.WT.A) Technical Data (EPRX.WT.A:CA) - Stock Traders Daily
Gains Report: Will APWS stock hit new highs in YEARQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Shorts Report: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEARTrade Signal Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Down 0.1% – Time to Sell? - Defense World
Market Overview: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Dynamic Trading Report - Stock Traders Daily
Risk Report: Whats the beta of Eupraxia Pharmaceuticals Inc stock2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Targets Report: Is PNFP a top pick in the sectorJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - baoquankhu1.vn
(EPRX) Strategic Market Analysis (EPRX:CA) - Stock Traders Daily
Aug Retail: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingWeekly Trade Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Catalysts: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demand2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
(EPRX) Trading Advice (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target Raised to $19.00 at Cantor Fitzgerald - Defense World
Cantor Fitzgerald Raises Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target to $19.00 - MarketBeat
Cantor Fitzgerald raises Eupraxia Pharmaceuticals stock price target to $19 By Investing.com - Investing.com UK
Buyback Watch: Will Lumentum Holdings Inc be affected by tariffsJuly 2025 Technicals & Free Community Supported Trade Ideas - baoquankhu1.vn
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Eupraxia Pharmaceuticals (TSX:EPRX) Price Target Increased by 21.11% to 14.96 - Nasdaq
Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Grows By 138.8% - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Price Target Increased by 21.61% to 10.82 - Nasdaq
(EPRX.WT.A) Investment Performance Report - Stock Traders Daily
Trend Report: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Trend Review & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Trading Action: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demandMarket Trend Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Macro Review: Can Eupraxia Pharmaceuticals Inc grow without dilution2025 Institutional Moves & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Trend Tracker for (EPRX) (EPRX:CA) - Stock Traders Daily
(EPRX) Trading Strategy and Analysis (EPRX:CA) - Stock Traders Daily
Can Eupraxia Pharmaceuticals Inc. stock sustain institutional interest2025 Key Highlights & Expert Verified Movement Alerts - Улправда
Eupraxia Pharmaceuticals’ (EPRX) Buy Rating Reaffirmed at HC Wainwright - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given Buy Rating at HC Wainwright - MarketBeat
Eupraxia Pharmaceuticals Inc. (TSE:EPRX) surges 15%; retail investors who own 41% shares profited along with institutions - simplywall.st
Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus - Sahm
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Earnings Impact & AI Forecasted Entry/Exit Points - Улправда
What insider trading reveals about Eupraxia Pharmaceuticals Inc. stockWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Is Eupraxia Pharmaceuticals Inc. stock a buy on dips2025 Price Action Summary & Stepwise Trade Signal Guides - Улправда
Will Eupraxia Pharmaceuticals Inc. stock continue dividend increases2025 Big Picture & Consistent Growth Stock Picks - Улправда
How Eupraxia Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
(EPRX.WT.A) Investment Analysis and Advice - Stock Traders Daily
Eupraxia Pharmaceuticals Inc Azioni (EPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):